Call for national prostate cancer screening program as late diagnoses rise

A review of prostate cancer screening guidance is underway, prompted by concerns over late diagnoses, especially in high-risk groups. Current testing relies on men requesting it, which has led to many being diagnosed too late. Prostate cancer is the second-most deadly cancer for men, with high-risk groups facing double the mortality rate. Advocates argue that a national screening program could significantly reduce late-stage diagnoses and deaths. On November 14, Prostate Cancer Research will present new data at a House of Commons event, highlighting the benefits of a national screening program. The organization calls for immediate action from the National Screening Committee and the government.